Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-25 @ 2:42 AM
NCT ID:
NCT02993133
Eligibility Criteria:
Inclusion Criteria:
* Age \> or = 18 years.
* Patient treated by Mycophénolate Mofétil (MMF) per os (Cellcept®) for an autoimmune bullous dermatose (pemphigus or cicatricial pemphigoid) for at least 30 days according to the recommendations (PNDS Pemphigus and cicatricial pemphigoid HAS 2011)
* Patient able to understand the nature, purpose and methodology of the study
* Patient affiliated to the French social security system or equivalent
* Patient who have signed an informed consent form
Exclusion Criteria:
* Pregnant or breast-feeding women or women of childbearing potential without efficient contraception (based on a declaration)
* Patient under legal protection.
* Patient deprived of freedom
* Patient with any altered mental status or any psychiatric condition that would interfere with the understanding of the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02993133
Study Brief:
Protocol Section:
NCT02993133